DuPont de Nemours (DD)
(Delayed Data from NYSE)
$86.59 USD
+2.26 (2.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $86.59 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$86.59 USD
+2.26 (2.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $86.59 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Zacks News
DuPont de Nemours (DD) Stock Moves -0.91%: What You Should Know
by Zacks Equity Research
DuPont de Nemours (DD) closed the most recent trading day at $81.79, moving -0.91% from the previous trading session.
DuPont de Nemours (DD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
DuPont de Nemours (DD) closed at $76.49 in the latest trading session, marking a +1.7% move from the prior day.
DuPont de Nemours (DD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
DuPont de Nemours (DD) closed the most recent trading day at $78.34, moving +0.9% from the previous trading session.
DuPont de Nemours (DD) Down 7.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Do Options Traders Know Something About DuPont (DD) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to for DuPont (DD) stock based on the movements in the options market lately.
International Flavors (IFF) Beats on Q3 Earnings & Sales, Up Y/Y
by Zacks Equity Research
International Flavors' (IFF) Q3 top line reflects benefits from solid growth in Nourish, Scent and Health & Biosciences as well as additional sales related to the merger with N&B business.
DuPont (DD) Tops Q3 Earnings & Sales Estimates, Cuts FY21 View
by Zacks Equity Research
DuPont (DD) benefits from strong end-market demand amid sustained headwinds from higher input costs and supply chain and logistics issues in Q3. It agrees to buy Rogers for $5.2 billion.
DuPont de Nemours (DD) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 2.68% and 4.34%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
DuPont (DD) Gears Up for Q3 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from higher demand and its cost and productivity actions amid headwinds from higher raw material costs in Q3.
DuPont de Nemours (DD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wall Street Analysts Believe DuPont de Nemours (DD) Could Rally 29%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 29% upside potential for DuPont de Nemours (DD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here's Why You Should Invest In DuPont (DD) Stock Now
by Zacks Equity Research
DuPont (DD) gains from strong demand, cost actions and innovation-driven investment.
DuPont (DD) Inks Deal With NextEra for 135MW of Clean Wind Energy
by Zacks Equity Research
DuPont (DD) signs an agreement with a NextEra subsidiary to generate 135 megawatts of wind power energy as a transition to renewable sources.
International Flavors (IFF) Updates 2021 Sales & EBITDA Guidance
by Zacks Equity Research
International Flavors (IFF) expects sales growth higher than 8% in 2021 and adjusted operating EBITDA margin to be approximately 21.5%.
4 Diversified Chemical Stocks to Watch Out for Amid Industry Woes
by Anindya Barman
Raw material cost pressure and demand worries due to chip shortage and the spread of the Delta variant pose as headwinds for the Zacks Chemicals Diversified industry. DOW, OLN, CC and AVNT are poised to survive the industry challenges.
Why Is DuPont de Nemours (DD) Down 1.1% Since Last Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
International Flavors (IFF) to Divest Microbial Control Business
by Zacks Equity Research
International Flavors' (IFF) latest deal enables it to focus on core business operations by strengthening the balance sheet, while maximizing shareholder returns.
International Flavors (IFF) Q2 Earnings Miss Estimates, Up Y/Y
by Zacks Equity Research
International Flavors' (IFF) Q2 top-line results reflect benefits from solid growth in Scent and Nourish as well as additional sales related to the merger with DuPont's Nutrition & Biosciences (N&B) business.
DuPont (DD) Tops Q2 Earnings & Sales Estimates, Raises FY21 View
by Zacks Equity Research
DuPont (DD) gains on a recovery in key end-markets such as automotive, construction and industrial and sustained strength in semiconductor and smartphones in Q2.
DuPont de Nemours (DD) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 12.77% and 3.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Why DuPont (DD) Might Surprise This Earnings Season
by Zacks Equity Research
DuPont (DD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Albemarle (ALB) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher volumes and prices in its lithium business in the second quarter.
Chemical Stock Q2 Earnings Due on Aug 3: DD, FMC, WLK & KWR
by Anindya Barman
Strong end-market demand and the benefits of strategic measures are likely to have aided the performance of chemical companies in Q2. Let's see how DD, FMC, WLK and KWR are poised ahead of their earnings releases.
3 Chemical Stocks Likely to Outshine Q2 Earnings Estimates
by Anindya Barman
Strong end-market demand and benefits of self-help actions are likely to reflect on the Q2 performance of Westlake (WLK), DuPont (DD) and Eastman Chemical (EMN).
DuPont (DD) Warms Up to Q2 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from its cost and productivity actions and higher demand in Q2 amid headwinds from higher raw material costs.